statistiche ricercatore

Continente	#
NA - Nord America	926
EU - Europa	616
AS - Asia	325
SA - Sud America	59
Continente sconosciuto - Info sul continente non disponibili	54
AF - Africa	27
OC - Oceania	1
Totale	2.008

Nazione	#
US - Stati Uniti d'America	894
RU - Federazione Russa	205
IT - Italia	149
SG - Singapore	114
IE - Irlanda	90
CN - Cina	88
BR - Brasile	48
VN - Vietnam	40
DE - Germania	32
GB - Regno Unito	30
FI - Finlandia	26
FR - Francia	26
HK - Hong Kong	26
SE - Svezia	22
CA - Canada	18
ZA - Sudafrica	13
KR - Corea	12
PL - Polonia	8
CZ - Repubblica Ceca	7
IN - India	6
BD - Bangladesh	5
MX - Messico	5
ES - Italia	4
HN - Honduras	4
JP - Giappone	4
KE - Kenya	4
AE - Emirati Arabi Uniti	3
AZ - Azerbaigian	3
EG - Egitto	3
IR - Iran	3
JO - Giordania	3
NL - Olanda	3
PK - Pakistan	3
TR - Turchia	3
UA - Ucraina	3
AR - Argentina	2
AT - Austria	2
CI - Costa d'Avorio	2
CO - Colombia	2
EC - Ecuador	2
EE - Estonia	2
IL - Israele	2
IQ - Iraq	2
JM - Giamaica	2
TN - Tunisia	2
AL - Albania	1
AU - Australia	1
BO - Bolivia	1
CH - Svizzera	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
DK - Danimarca	1
GE - Georgia	1
GT - Guatemala	1
ID - Indonesia	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LB - Libano	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
MD - Moldavia	1
MU - Mauritius	1
MY - Malesia	1
NI - Nicaragua	1
PR - Porto Rico	1
SA - Arabia Saudita	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
SR - Suriname	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.955

Nome	#
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction	455
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up	226
Risk stratification in cardiogenic shock: a focus on the available evidence	181
Biomarkers predict in-hospital major adverse cardiac events in covid-19 patients: A multicenter international study	175
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences	165
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning	165
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization	151
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence	142
Current and emerging drug targets in heart failure treatment	135
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction	112
Strain echocardiography for the prognostic estimation of patients with sarcoidosis	101
Totale	2.008

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	51	0	0	0	0	0	0	17	7	0	5	8	14
2022/2023	135	5	12	12	9	11	17	8	15	10	8	6	22
2023/2024	176	10	8	20	20	8	30	67	1	1	5	0	6
2024/2025	359	16	12	36	13	52	27	14	18	40	20	35	76
2025/2026	1.112	64	95	421	95	183	26	71	15	22	46	17	57
2026/2027	175	14	18	65	78	0	0	0	0	0	0	0	0
Totale													2.008